Group 1 - The A-share market saw increased activity in the decelerator concept stocks, with Fuda Co., Ltd. hitting the daily limit up [1] - Other companies such as Jindao Technology, Jingzhu Technology, Haoneng Co., Ltd., Longsheng Technology, Zhongdali De, and Lixing Co., Ltd. also experienced gains [1]

证券代码：300421 证券简称：力星股份 公告编号：2025-020 江苏力星通用钢球股份有限公司 关于董事、高级管理人员减持股份预披露的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导 性陈述或重大遗漏。 特别提示： 1、持本公司股份3,566,275股（占本公司总股本比例1.21%）的董事、副总经 理、总工程师赵高明先生计划自本公告披露之日起15个交易日后的3个月内通过 集中竞价交易方式减持公司股份不超过880,000股，占公司总股本比例0.30%。 2、持本公司股份2,639,284股（占本公司总股本比例0.90%）的董事、副总经 理汤国华先生计划自本公告披露之日起15个交易日后的3个月内通过集中竞价交 易方式减持公司股份不超过650,000股，占公司总股本比例0.22%。 3、持本公司股份2,639,284股（占本公司总股本比例0.90%）的总经理助理沙 小建先生计划自本公告披露之日起15个交易日后的3个月内通过集中竞价交易方 式减持公司股份不超过650,000股，占公司总股本比例0.22%。 江苏力星通用钢球股份有限公司（以下简称"公司"）近日收到公司股东赵高 明 ...

Mergers and Acquisitions - Conch New Materials plans to acquire 80% of Kangning Special Environmental Technology Co., Ltd. and 100% of Zhengzhou Kangning Special Environmental Engineering Technology Co., Ltd. for a total transaction price of approximately 186 million yuan, with final pricing subject to adjustments based on asset valuations at the time of management transfer [1] - BOE Technology Group intends to acquire 30% of Xianyang Rainbow Optoelectronics Technology Co., Ltd. through a public bidding process, with a starting price of 4.849 billion yuan [2] - Wutong Holdings aims to purchase 20% of Suzhou Wutong Intelligent Electronics Co., Ltd. for 84 million yuan to enhance its smart manufacturing business [3] Shareholding Changes - SITW announced that the National Integrated Circuit Industry Investment Fund II has reduced its shareholding from 7.35% to 6.99% after selling 1.45 million shares [4] - Double Fly Group's shareholders plan to collectively reduce their holdings by no more than 210,000 shares, with specific reductions of 90,000 shares and 120,000 shares from two different shareholders [5] - Lixing Co., Ltd. executives plan to reduce their holdings by a total of 218,000 shares, with individual reductions of 88,000 shares, 65,000 shares, and 65,000 shares [6]

Group 1 - The company Jiangsu Lixing General Steel Ball Co., Ltd. announced that three executives plan to reduce their shareholdings, with a total maximum reduction of 2,180,000 shares, accounting for 0.74% of the company's total share capital [1][2] - Executive Zhao Gaoming plans to reduce his holdings by up to 880,000 shares, representing 0.30% of the total share capital [1] - Executives Tang Guohua and Sha Xiaojian each plan to reduce their holdings by up to 650,000 shares, each representing 0.22% of the total share capital [1] Group 2 - As of the announcement date, Zhao Gaoming holds 3,566,275 shares (1.21%), Tang Guohua holds 2,639,284 shares (0.90%), and Sha Xiaojian holds 2,639,284 shares (0.90%), totaling 8,844,843 shares (3.01%) [1] - The reduction plan will be executed within three months after a 15-trading-day period following the announcement, adhering to relevant regulations regarding insider trading and stock sales by executives [2] - The company assures that the implementation of this reduction plan will not lead to a change in control or affect the governance structure and ongoing operations of the company [2]

Summary of Key Points - The company Lixing Co., Ltd. (300421) announced that its board member, deputy general manager, and chief engineer Zhao Gaoming plans to reduce his holdings by no more than 880,000 shares, which accounts for 0.30% of the company's total share capital [1] - Additionally, board member and deputy general manager Tang Guohua intends to reduce his holdings by no more than 650,000 shares, representing 0.22% of the total share capital [1] - Assistant general manager Sha Xiaojian also plans to reduce his holdings by no more than 650,000 shares, which is 0.22% of the total share capital [1] - The method of reduction will be through centralized bidding transactions, with the period set from July 9, 2025, to October 8, 2025 [1] - The reason for the reduction in holdings is stated as personal financial needs [1]

Group 1 - Company GuoDeWei plans to repurchase shares with a total investment of between 100 million to 150 million yuan, with a maximum repurchase price of 53 yuan per share, expecting to buy back between 1.89 million to 2.83 million shares, accounting for 0.78% to 1.17% of total share capital [1] - Company Shuangliang Energy has won a bid for the Gansu Energy Chemical Qinyang 2×660MW coal power project, with a total bid amount of 237 million yuan, representing 1.82% of the company's projected revenue for 2024 [1] - Company China Pacific Insurance reported a total premium income of 227.17 billion yuan from its two subsidiaries in the first five months, with a year-on-year growth of 10.2% for its life insurance subsidiary and 0.5% for its property insurance subsidiary [1][2] Group 2 - Company LuKang Pharmaceutical has received a drug registration certificate for injectable Cefoperazone Sodium, a third-generation cephalosporin with broad-spectrum antibacterial properties [3] - Company 吉祥航空 reported a 4.97% year-on-year increase in passenger turnover in May, with a seat occupancy rate of 86.14%, up 3.70% year-on-year [4][5] - Company DuRui Pharmaceutical's subsidiary has also received a drug registration certificate for injectable Cefoperazone Sodium [6] Group 3 - Company KeLan Software announced that part of the shares held by its controlling shareholder will be auctioned, involving 5.09 million shares, accounting for 1.07% of the total share capital [7] - Company HuaCan Optoelectronics received a government subsidy of 87.84 million yuan, which is expected to positively impact the company's pre-tax profit for 2025 [8] - Company JinZhi Technology has won a bid for projects from the State Grid and China Resources New Energy, with a total bid amount of 84.41 million yuan [9] Group 4 - Company Vision China completed a capital increase for its subsidiary, raising 100 million yuan to accelerate its layout in the AI field [11] - Company Youa Co. received a profit distribution of 96.03 million yuan from its investment in Changsha Bank [13] - Company WanBangde's subsidiary obtained a patent for a deuterated compound, enhancing the chemical stability and reducing toxicity [16] Group 5 - Company DongCheng Pharmaceutical completed the enrollment of all 488 participants in the Phase III clinical trial for Fluorine-18 PSMA peptide injection, aimed at prostate cancer diagnosis [17] - Company China Merchants Expressway announced that its first phase of medium-term notes for 2024 will pay interest on July 2, 2025, with a total issuance of 2.5 billion yuan and an interest rate of 2.35% [18] - Company JinPu Titanium's subsidiary has temporarily suspended production for maintenance due to falling product prices and high production costs [20] Group 6 - Company BeiLu Pharmaceutical received a marketing authorization for Iodinated Contrast Injection in Hungary, marking another approval in the EU [22] - Company LiXing Co. obtained an overseas investment certificate for its wholly-owned subsidiary in Singapore, with a total investment of 2.16 million yuan [24] - Company LangKun Technology won a garbage collection service project with a bid amount of 21.57 million yuan [26] Group 7 - Company KeRui International plans to transfer 55% of its subsidiary Tianjin ZhiRui's equity for 41.96 million yuan [28] - Company Nanjing JuLong intends to invest 130 million yuan to build a production project for special materials with an annual output of 40,000 tons [30] - Company NanShan Intelligent plans to use up to 50 million yuan of idle funds for cash management in safe and liquid financial products [32] Group 8 - Company GuangLian Aviation completed the business change registration for its subsidiary, involving the introduction of strategic investors [34] - Company XiaoFang Pharmaceutical signed a cooperation agreement to develop a new drug for hair loss treatment [36] - Company GuiZhou SanLi plans to sign a 150 million yuan technology transfer and development contract with Guangdong Pharmaceutical University [38] Group 9 - Company ST SiLong's subsidiary received a drug registration certificate for Famotidine injection, used for treating upper gastrointestinal bleeding [52] - Company ZhongKe Information's executive plans to reduce holdings of up to 180,000 shares, accounting for 0.06% of total share capital [53] - Company KeLun Pharmaceutical's injectable Cefoperazone Sodium/Chloride Sodium injection received drug registration approval [54] Group 10 - Company LuXin Investment plans to transfer 10.06% of its stake in LuXin HuiJin for 203 million yuan, aiming to focus on its main business [56] - Company Western Gold plans to acquire 100% of Xinjiang MeiSheng for 1.655 billion yuan [58] - Company JinTou City Development intends to swap assets worth 5.862 billion yuan, changing its main business to urban centralized heating [60]

证券代码：300421 证券简称：力星股份 公告编号：2025-019 江苏力星通用钢球股份有限公司 关于取得企业境外投资证书的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导 性陈述或重大遗漏。 江苏力星通用钢球股份有限公司（以下简称"公司"）根据公司经营发展及战 略规划，经董事长审批通过，公司在新加坡设立了全资子公司江苏力星（新加坡） 私人有限公司（英文名：JGBR（SINGAPORE）PTE.LTD.），内容详见公司 2025 年 3 月 14 日在中国证监会指定创业板信息披露网站上刊登的《关于投资设立新 加坡全资子公司的公告》。 近日公司取得江苏省商务厅颁发的《企业境外投资证书》。现就相关情况公 告如下： 1、境外企业名称：江苏力星（新加坡）私人有限公司 2、国家/地区：新加坡 3、设立方式：新设 4、投资主体：江苏力星通用钢球股份有限公司，股比：100% 5、投资总额：216 万人民币（折合 30 万美元） 6、经营范围：机械设备及配件销售贸易、机械设备的安装及维护。 7、核准或备案文号：苏境外投资【2025】N00772 号 特此公告。 江苏力星通用钢球股份有限公 ...

Group 1 - Lixing Co., Ltd. has experienced a continuous decline in stock price for six consecutive trading days, with a cumulative drop of -8.96% [1] - Lixing Co., Ltd. specializes in the production and sales of high-precision bearing rolling elements and is recognized as a national high-tech enterprise, established in 1989 and listed on the Shenzhen Stock Exchange in 2015 [1] - The fund manager of Guoshou Anbao Smart Life Stock A, Zhang Qi, has increased holdings in Lixing Co., Ltd. during the first quarter of this year, with a year-to-date return of 4.07%, ranking 378 out of 979 in its category [1][3] Group 2 - The stock performance of Lixing Co., Ltd. shows a near-term decline of -2.06% over the past week and a year-to-date increase of 4.07%, compared to the average performance of its peers [2] - The company’s stock has seen a -10.15% decline over the past three months, while the Shanghai and Shenzhen 300 index has decreased by -2.52% in the same period [2] - Guoshou Anbao Fund Management Co., Ltd. was established in October 2013, with China Life Asset Management Co., Ltd. holding 85.03% of the shares [4]

力星股份（300421）公告，持本公司股份355.43万股的董事、副总经理王嵘计划自公告披露之日起15个 交易日后的3个月内，通过集中竞价交易方式减持不超过85万股，占公司总股本比例0.29%。 ...

江苏力星通用钢球股份有限公司 关于董事、高级管理人员减持股份预披露的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导 性陈述或重大遗漏。 特别提示： 1、持本公司股份3,554,274股（占本公司总股本比例1.21%）的董事、副总经 理王嵘先生计划自本公告披露之日起15个交易日后的3个月内通过集中竞价交易 方式减持公司股份不超过850,000股，占公司总股本比例0.29%。 2、持本公司股份2,639,284股（占本公司总股本比例0.90%）的总经理助理、 董事会秘书陈芳女士计划自本公告披露之日起15个交易日后的3个月内通过集中 竞价交易方式减持公司股份不超过400,000股，占公司总股本比例0.22%。 3、持本公司股份2,637,911 股（占本公司总股本比例0.90%）的总经理助理 苏银建先生计划自本公告披露之日起15个交易日后的3个月内通过集中竞价交易 方式减持公司股份不超过650,000股，占公司总股本比例0.22%。 证券代码：300421 证券简称：力星股份 公告编号：2025-018 | 股东名称 | | 任职情况 | 截至本公告日持股数量（股） | 占公司总 ...